Loading…
Reduced GABA/glutamate in the thalamus of individuals at clinical high risk for psychosis
Youth at clinical high risk (CHR) are a unique population enriched for precursors of major psychiatric disorders, especially schizophrenia (SCZ). Recent neuroimaging findings point to abnormalities in the thalamus of patients with SCZ, including chronic and early course patients, as well as in CHR i...
Saved in:
Published in: | Neuropsychopharmacology (New York, N.Y.) N.Y.), 2021-05, Vol.46 (6), p.1133-1139 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c430t-f0270a64847786ad346c148e7ce50b022e788e43bd02c218a246ceeaba1a15473 |
---|---|
cites | cdi_FETCH-LOGICAL-c430t-f0270a64847786ad346c148e7ce50b022e788e43bd02c218a246ceeaba1a15473 |
container_end_page | 1139 |
container_issue | 6 |
container_start_page | 1133 |
container_title | Neuropsychopharmacology (New York, N.Y.) |
container_volume | 46 |
creator | Quiñones, Gonzalo M Mayeli, Ahmad Yushmanov, Victor E Hetherington, Hoby P Ferrarelli, Fabio |
description | Youth at clinical high risk (CHR) are a unique population enriched for precursors of major psychiatric disorders, especially schizophrenia (SCZ). Recent neuroimaging findings point to abnormalities in the thalamus of patients with SCZ, including chronic and early course patients, as well as in CHR individuals relative to healthy comparison groups, thus suggesting that thalamic dysfunctions are present even before illness onset. Furthermore, modeling data indicate that alteration between excitatory and inhibitory control, as reflected by alteration in GABAergic and glutamatergic balance (i.e., GABA/Glu), may underlie thalamic deficits linked to the risk and development of psychosis. There is, however, a lack of in vivo evidence of GABA/Glu thalamic abnormalities in the CHR state. Magnetic resonance spectroscopic imaging (MRSI) 7 Tesla (7 T) provides enhanced resolution to quantify GABA and Glu levels in the thalamus of CHR individuals. In this study, we performed 7 T MRSI in 15 CHR and 20 healthy control (HC) participants. We found that GABA/Glu was significantly reduced in the right medial anterior and right medial posterior thalamus of CHR relative to HC groups. The GABA/Glu reduction was negatively correlated with general symptoms in the right medial anterior thalamus, as well as with disorganization symptoms in the right medial posterior thalamus. Altogether, these findings indicate that GABA/Glu abnormalities are present in the thalamus before the onset of full-blown psychosis and are associated with symptom severity, thus providing putative molecular and neuronal targets for early interventions in youth at CHR. |
doi_str_mv | 10.1038/s41386-020-00920-4 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8115482</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2467619809</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-f0270a64847786ad346c148e7ce50b022e788e43bd02c218a246ceeaba1a15473</originalsourceid><addsrcrecordid>eNpdkV9rFDEUxYNY7Lb6BXyQgC--jL35s5Psi7AtWgsFQRTqU7ibubOTOjNZk5lCv71pt5bWhySQnHNyLj_G3gr4KEDZk6yFsnUFEiqAVdn1C7YQRkNVK331ki3ArlQllLo6ZEc5XwOIpantK3aolDTKQL1gv75TM3tq-Pn6dH2y7ecJB5yIh5FPHZWFPQ5z5rEtV024Cc2MfeY4cd-HMXjseRe2HU8h_-ZtTHyXb30Xc8iv2UFbpPTm4TxmP798_nH2tbr8dn5xtr6svFYwVS1IA1hrq42xNTZK115oS8bTEjYgJRlrSatNA9JLYVEWARFuUKBYaqOO2ad97m7eDNR4GqeEvdulMGC6dRGDe_4yhs5t442zovitLAEfHgJS_DNTntwQsqe-x5HinF350NRiZWFVpO__k17HOY1lPCeXpbVRYO4ayb3Kp5hzovaxjAB3R87tyblCzt2Tc7qY3j0d49HyD5X6C9A6lDY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2514873077</pqid></control><display><type>article</type><title>Reduced GABA/glutamate in the thalamus of individuals at clinical high risk for psychosis</title><source>Nexis UK</source><source>Open Access: PubMed Central</source><source>Springer Link</source><creator>Quiñones, Gonzalo M ; Mayeli, Ahmad ; Yushmanov, Victor E ; Hetherington, Hoby P ; Ferrarelli, Fabio</creator><creatorcontrib>Quiñones, Gonzalo M ; Mayeli, Ahmad ; Yushmanov, Victor E ; Hetherington, Hoby P ; Ferrarelli, Fabio</creatorcontrib><description>Youth at clinical high risk (CHR) are a unique population enriched for precursors of major psychiatric disorders, especially schizophrenia (SCZ). Recent neuroimaging findings point to abnormalities in the thalamus of patients with SCZ, including chronic and early course patients, as well as in CHR individuals relative to healthy comparison groups, thus suggesting that thalamic dysfunctions are present even before illness onset. Furthermore, modeling data indicate that alteration between excitatory and inhibitory control, as reflected by alteration in GABAergic and glutamatergic balance (i.e., GABA/Glu), may underlie thalamic deficits linked to the risk and development of psychosis. There is, however, a lack of in vivo evidence of GABA/Glu thalamic abnormalities in the CHR state. Magnetic resonance spectroscopic imaging (MRSI) 7 Tesla (7 T) provides enhanced resolution to quantify GABA and Glu levels in the thalamus of CHR individuals. In this study, we performed 7 T MRSI in 15 CHR and 20 healthy control (HC) participants. We found that GABA/Glu was significantly reduced in the right medial anterior and right medial posterior thalamus of CHR relative to HC groups. The GABA/Glu reduction was negatively correlated with general symptoms in the right medial anterior thalamus, as well as with disorganization symptoms in the right medial posterior thalamus. Altogether, these findings indicate that GABA/Glu abnormalities are present in the thalamus before the onset of full-blown psychosis and are associated with symptom severity, thus providing putative molecular and neuronal targets for early interventions in youth at CHR.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/s41386-020-00920-4</identifier><identifier>PMID: 33273706</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Adolescent ; gamma-Aminobutyric Acid ; Glutamatergic transmission ; Glutamic Acid ; Humans ; Magnetic Resonance Imaging ; Magnetic resonance spectroscopy ; Mental disorders ; Neural stem cells ; Neuroimaging ; Neurotransmitters ; Psychosis ; Psychotic Disorders - diagnostic imaging ; Schizophrenia ; Schizophrenia - diagnostic imaging ; Thalamus ; Thalamus - diagnostic imaging ; γ-Aminobutyric acid</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2021-05, Vol.46 (6), p.1133-1139</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Switzerland AG part of Springer Nature 2020.</rights><rights>The Author(s), under exclusive licence to Springer Nature Switzerland AG part of Springer Nature 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-f0270a64847786ad346c148e7ce50b022e788e43bd02c218a246ceeaba1a15473</citedby><cites>FETCH-LOGICAL-c430t-f0270a64847786ad346c148e7ce50b022e788e43bd02c218a246ceeaba1a15473</cites><orcidid>0000-0002-3633-7380</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115482/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115482/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33273706$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quiñones, Gonzalo M</creatorcontrib><creatorcontrib>Mayeli, Ahmad</creatorcontrib><creatorcontrib>Yushmanov, Victor E</creatorcontrib><creatorcontrib>Hetherington, Hoby P</creatorcontrib><creatorcontrib>Ferrarelli, Fabio</creatorcontrib><title>Reduced GABA/glutamate in the thalamus of individuals at clinical high risk for psychosis</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacology</addtitle><description>Youth at clinical high risk (CHR) are a unique population enriched for precursors of major psychiatric disorders, especially schizophrenia (SCZ). Recent neuroimaging findings point to abnormalities in the thalamus of patients with SCZ, including chronic and early course patients, as well as in CHR individuals relative to healthy comparison groups, thus suggesting that thalamic dysfunctions are present even before illness onset. Furthermore, modeling data indicate that alteration between excitatory and inhibitory control, as reflected by alteration in GABAergic and glutamatergic balance (i.e., GABA/Glu), may underlie thalamic deficits linked to the risk and development of psychosis. There is, however, a lack of in vivo evidence of GABA/Glu thalamic abnormalities in the CHR state. Magnetic resonance spectroscopic imaging (MRSI) 7 Tesla (7 T) provides enhanced resolution to quantify GABA and Glu levels in the thalamus of CHR individuals. In this study, we performed 7 T MRSI in 15 CHR and 20 healthy control (HC) participants. We found that GABA/Glu was significantly reduced in the right medial anterior and right medial posterior thalamus of CHR relative to HC groups. The GABA/Glu reduction was negatively correlated with general symptoms in the right medial anterior thalamus, as well as with disorganization symptoms in the right medial posterior thalamus. Altogether, these findings indicate that GABA/Glu abnormalities are present in the thalamus before the onset of full-blown psychosis and are associated with symptom severity, thus providing putative molecular and neuronal targets for early interventions in youth at CHR.</description><subject>Adolescent</subject><subject>gamma-Aminobutyric Acid</subject><subject>Glutamatergic transmission</subject><subject>Glutamic Acid</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Magnetic resonance spectroscopy</subject><subject>Mental disorders</subject><subject>Neural stem cells</subject><subject>Neuroimaging</subject><subject>Neurotransmitters</subject><subject>Psychosis</subject><subject>Psychotic Disorders - diagnostic imaging</subject><subject>Schizophrenia</subject><subject>Schizophrenia - diagnostic imaging</subject><subject>Thalamus</subject><subject>Thalamus - diagnostic imaging</subject><subject>γ-Aminobutyric acid</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpdkV9rFDEUxYNY7Lb6BXyQgC--jL35s5Psi7AtWgsFQRTqU7ibubOTOjNZk5lCv71pt5bWhySQnHNyLj_G3gr4KEDZk6yFsnUFEiqAVdn1C7YQRkNVK331ki3ArlQllLo6ZEc5XwOIpantK3aolDTKQL1gv75TM3tq-Pn6dH2y7ecJB5yIh5FPHZWFPQ5z5rEtV024Cc2MfeY4cd-HMXjseRe2HU8h_-ZtTHyXb30Xc8iv2UFbpPTm4TxmP798_nH2tbr8dn5xtr6svFYwVS1IA1hrq42xNTZK115oS8bTEjYgJRlrSatNA9JLYVEWARFuUKBYaqOO2ad97m7eDNR4GqeEvdulMGC6dRGDe_4yhs5t442zovitLAEfHgJS_DNTntwQsqe-x5HinF350NRiZWFVpO__k17HOY1lPCeXpbVRYO4ayb3Kp5hzovaxjAB3R87tyblCzt2Tc7qY3j0d49HyD5X6C9A6lDY</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Quiñones, Gonzalo M</creator><creator>Mayeli, Ahmad</creator><creator>Yushmanov, Victor E</creator><creator>Hetherington, Hoby P</creator><creator>Ferrarelli, Fabio</creator><general>Nature Publishing Group</general><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3633-7380</orcidid></search><sort><creationdate>20210501</creationdate><title>Reduced GABA/glutamate in the thalamus of individuals at clinical high risk for psychosis</title><author>Quiñones, Gonzalo M ; Mayeli, Ahmad ; Yushmanov, Victor E ; Hetherington, Hoby P ; Ferrarelli, Fabio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-f0270a64847786ad346c148e7ce50b022e788e43bd02c218a246ceeaba1a15473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>gamma-Aminobutyric Acid</topic><topic>Glutamatergic transmission</topic><topic>Glutamic Acid</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Magnetic resonance spectroscopy</topic><topic>Mental disorders</topic><topic>Neural stem cells</topic><topic>Neuroimaging</topic><topic>Neurotransmitters</topic><topic>Psychosis</topic><topic>Psychotic Disorders - diagnostic imaging</topic><topic>Schizophrenia</topic><topic>Schizophrenia - diagnostic imaging</topic><topic>Thalamus</topic><topic>Thalamus - diagnostic imaging</topic><topic>γ-Aminobutyric acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quiñones, Gonzalo M</creatorcontrib><creatorcontrib>Mayeli, Ahmad</creatorcontrib><creatorcontrib>Yushmanov, Victor E</creatorcontrib><creatorcontrib>Hetherington, Hoby P</creatorcontrib><creatorcontrib>Ferrarelli, Fabio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quiñones, Gonzalo M</au><au>Mayeli, Ahmad</au><au>Yushmanov, Victor E</au><au>Hetherington, Hoby P</au><au>Ferrarelli, Fabio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced GABA/glutamate in the thalamus of individuals at clinical high risk for psychosis</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><addtitle>Neuropsychopharmacology</addtitle><date>2021-05-01</date><risdate>2021</risdate><volume>46</volume><issue>6</issue><spage>1133</spage><epage>1139</epage><pages>1133-1139</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><abstract>Youth at clinical high risk (CHR) are a unique population enriched for precursors of major psychiatric disorders, especially schizophrenia (SCZ). Recent neuroimaging findings point to abnormalities in the thalamus of patients with SCZ, including chronic and early course patients, as well as in CHR individuals relative to healthy comparison groups, thus suggesting that thalamic dysfunctions are present even before illness onset. Furthermore, modeling data indicate that alteration between excitatory and inhibitory control, as reflected by alteration in GABAergic and glutamatergic balance (i.e., GABA/Glu), may underlie thalamic deficits linked to the risk and development of psychosis. There is, however, a lack of in vivo evidence of GABA/Glu thalamic abnormalities in the CHR state. Magnetic resonance spectroscopic imaging (MRSI) 7 Tesla (7 T) provides enhanced resolution to quantify GABA and Glu levels in the thalamus of CHR individuals. In this study, we performed 7 T MRSI in 15 CHR and 20 healthy control (HC) participants. We found that GABA/Glu was significantly reduced in the right medial anterior and right medial posterior thalamus of CHR relative to HC groups. The GABA/Glu reduction was negatively correlated with general symptoms in the right medial anterior thalamus, as well as with disorganization symptoms in the right medial posterior thalamus. Altogether, these findings indicate that GABA/Glu abnormalities are present in the thalamus before the onset of full-blown psychosis and are associated with symptom severity, thus providing putative molecular and neuronal targets for early interventions in youth at CHR.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>33273706</pmid><doi>10.1038/s41386-020-00920-4</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-3633-7380</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-133X |
ispartof | Neuropsychopharmacology (New York, N.Y.), 2021-05, Vol.46 (6), p.1133-1139 |
issn | 0893-133X 1740-634X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8115482 |
source | Nexis UK; Open Access: PubMed Central; Springer Link |
subjects | Adolescent gamma-Aminobutyric Acid Glutamatergic transmission Glutamic Acid Humans Magnetic Resonance Imaging Magnetic resonance spectroscopy Mental disorders Neural stem cells Neuroimaging Neurotransmitters Psychosis Psychotic Disorders - diagnostic imaging Schizophrenia Schizophrenia - diagnostic imaging Thalamus Thalamus - diagnostic imaging γ-Aminobutyric acid |
title | Reduced GABA/glutamate in the thalamus of individuals at clinical high risk for psychosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A15%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20GABA/glutamate%20in%20the%20thalamus%20of%20individuals%20at%20clinical%20high%20risk%20for%20psychosis&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=Qui%C3%B1ones,%20Gonzalo%20M&rft.date=2021-05-01&rft.volume=46&rft.issue=6&rft.spage=1133&rft.epage=1139&rft.pages=1133-1139&rft.issn=0893-133X&rft.eissn=1740-634X&rft_id=info:doi/10.1038/s41386-020-00920-4&rft_dat=%3Cproquest_pubme%3E2467619809%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-f0270a64847786ad346c148e7ce50b022e788e43bd02c218a246ceeaba1a15473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2514873077&rft_id=info:pmid/33273706&rfr_iscdi=true |